Skip to content

TECO®Fast Cryptococcus Antigen LFA 

Key Features


For early diagnosis of Cryptococcus infections such as Cryptococcus meningitis, and as a monitoring tool during therapy.

Product Description



Fast Cryptococcus neoformans Ag Lateral Flow Assay is used for the detection of cryptococcal capsular polysaccharide antigen in human serum/cerebral spinal fluid (CSF), offering a diagnostic reference for cryptococcal meningitis infection.


  • Fluorescence-based lateral flow assay designed for readout via reader.
  • Quantitative determination of the Cryptococcus antigen glycuronoxylomannan (GXM) in ng/mL in only 20 minutes.
  • Detects the respective serotypes A, B, C, D and AD.
  • Clinically validated for CSF and serum samples.
  • No sample treatment required.
  • Limit of detection: 0.1 ng/mL, clinical cut-off value: 0.5 ng/mL.

Request Quotation


Product
SKU
Pack Size
Qty
TECO®Fast Cryptococcus Antigen LFA
SKU
TE1085
Pack Size
50 tests

Request Documentation


TECO®Fast Cryptococcus Antigen LFA
TE1085

Latest News


New Distribution Partnership with UTAK for Toxicology Quality Control Solutions

Eurobio Scientific UK is thrilled to announce its new partnership with UTAK, an esteemed American company specialising in Toxicology quality control solutions.

BioGX Candida Auris PCR Assay Global Adoption Accelerates

BioGX, a global provider of easy molecular diagnostic solutions, announced accelerated adoption of their high performance Sample-Readyâ„¢ PCR assay for detection of Candida auris, a rapidly spreading, hard to treat fungus with a growing presence in hospitals and long-term care facilities.

New Partnership - Haematex

Developing and providing better laboratory methods for investigating blood clotting and bleeding disorders.

Eurobio Scientific acquires Pathway Diagnostics

Eurobio Scientific acquires Surrey based Pathway Diagnostics Ltd. Pathway Diagnostics Ltd have been supplying haemostasis, immunology, quality control materials and infectious disease products as a distributor and manufacturer to the UK and Ireland IVD, research, and industrial markets since 1998.

Contact Us